Human Marrow Stromal Cells Downsize the Stem Cell Fraction of Lung Cancers by Fibroblast Growth Factor 10

REFERENCES

• Bunn PAJr. 2012. Worldwide overview of the current status of lung cancer diagnosis and treatment. Arch. Pathol. Lab. Med. 136:1478–1481. http://dx.doi.org/10.5858/arpa.2012-0295-SA.
   PubMed Web of Science ®Google Scholar
• Gottschling S, Schnabel PA, Herth FJ, Herpel E. 2012. Are we missing the target? Cancer stem cells and drug resistance in non-small cell lung cancer. Cancer Genomics Proteomics 9:275–286. http://cgp.iiarjournals.org/content/9/5/275.long.
   PubMedGoogle Scholar
• Jiang W, Peng J, Zhang Y, Cho WC, Jin K. 2012. The implications of cancer stem cells for cancer therapy. Int. J. Mol. Sci. 13:16636–16657. http://dx.doi.org/10.3390/ijms131216636.
   PubMedGoogle Scholar
• Wu X, Chen H, Wang X. 2012. Can lung cancer stem cells be targeted for therapies? Cancer Treat. Rev. 38:580–588. http://dx.doi.org/10.1016/j.ctrv.2012.02.013.
   PubMedGoogle Scholar
• Tirino V, Desiderio V, Paino F, De Rosa A, Papaccio F, La Noce M, Laino L, De Francesco F, Papaccio G. 2013. Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization. FASEB J. 27:13–24. http://dx.doi.org/10.1096/fj.12-218222.
   PubMed Web of Science ®Google Scholar
• Marjanovic ND, Weinberg RA, Chaffer CL. 2013. Cell plasticity and heterogeneity in cancer. Clin. Chem. 59:168–179. http://dx.doi.org/10.1373/clinchem.2012.184655.
   PubMed Web of Science ®Google Scholar
• Baccelli I, Trumpp A. 2012. The evolving concept of cancer and metastasis stem cells. J. Cell Biol. 198:281–293. http://dx.doi.org/10.1083/jcb.201202014.
   PubMed Web of Science ®Google Scholar
• Tang DG. 2012. Understanding cancer stem cell heterogeneity and plasticity. Cell Res. 22:457–472. http://dx.doi.org/10.1038/cr.2012.13.
   PubMed Web of Science ®Google Scholar
• Bergfeld SA, DeClerck YA. 2010. Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metastasis Rev. 29:249–261. http://dx.doi.org/10.1007/s10555-010-9222-7.
   PubMed Web of Science ®Google Scholar
• Keating A. 2012. Mesenchymal stromal cells: new directions. Cell Stem Cell 10:709–716. http://dx.doi.org/10.1016/j.stem.2012.05.015.
   PubMed Web of Science ®Google Scholar
• Klopp AH, Gupta A, Spaeth E, Andreeff M, Marini F3rd. 2011. Concise review. Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? Stem Cells 29:11–19. http://dx.doi.org/10.1002/stem.559.
   PubMed Web of Science ®Google Scholar
• Torsvik A, Bjerkvig R. 2013. Mesenchymal stem cell signaling in cancer progression. Cancer Treat. Rev. 39:180–188. http://dx.doi.org/10.1016/j.ctrv.2012.03.005.
   PubMedGoogle Scholar
• Kanehira M, Kikuchi T, Ohkouchi S, Shibahara T, Tode N, Santoso A, Daito H, Ohta H, Tamada T, Nukiwa T. 2012. Targeting lysophosphatidic acid signaling retards culture-associated senescence of human marrow stromal cells. PLoS One 7:e32185. http://dx.doi.org/10.1371/journal.pone.0032185.
   PubMedGoogle Scholar
• Zaini J, Andarini S, Tahara M, Saijo Y, Ishii N, Kawakami K, Taniguchi M, Sugamura K, Nukiwa T, Kikuchi T. 2007. OX40 ligand expressed by DCs costimulates NKT and CD4+ Th cell antitumor immunity in mice. J. Clin. Invest. 117:3330–3338. http://dx.doi.org/10.1172/JCI32693.
   PubMedGoogle Scholar
• Mafi P, Hindocha S, Mafi R, Griffin M, Khan WS. 2011. Adult mesenchymal stem cells and cell surface characterization—a systematic review of the literature. Open Orthop. J. 5:253–260. http://dx.doi.org/10.2174/1874325001105010253.
   PubMedGoogle Scholar
• Nery AA, Nascimento IC, Glaser T, Bassaneze V, Krieger JE, Ulrich H. 2013. Human mesenchymal stem cells: from immunophenotyping by flow cytometry to clinical applications. Cytometry A 83:48–61. http://dx.doi.org/10.1002/cyto.a.22205.
   PubMedGoogle Scholar
• Metzger RJ, Krasnow MA. 1999. Genetic control of branching morphogenesis. Science 284:1635–1639. http://dx.doi.org/10.1126/science.284.5420.1635.
   PubMed Web of Science ®Google Scholar
• Warburton D, Schwarz M, Tefft D, Flores-Delgado G, Anderson KD, Cardoso WV. 2000. The molecular basis of lung morphogenesis. Mech. Dev. 92:55–81. http://dx.doi.org/10.1016/S0925-4773(99)00325-1.
   PubMed Web of Science ®Google Scholar
• Maugeri-Sacca M, Vigneri P, De Maria R. 2011. Cancer stem cells and chemosensitivity. Clin. Cancer Res. 17:4942–4947. http://dx.doi.org/10.1158/1078-0432.CCR-10-2538.
   PubMedGoogle Scholar
• Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U, Goodell MA, Brenner MK. 2004. A distinct “side population” of cells with high drug efflux capacity in human tumor cells. Proc. Natl. Acad. Sci. U. S. A. 101:14228–14233. http://dx.doi.org/10.1073/pnas.0400067101.
   PubMed Web of Science ®Google Scholar
• Ito K, Bernardi R, Morotti A, Matsuoka S, Saglio G, Ikeda Y, Rosenblatt J, Avigan DE, Teruya-Feldstein J, Pandolfi PP. 2008. PML targeting eradicates quiescent leukaemia-initiating cells. Nature 453:1072–1078. http://dx.doi.org/10.1038/nature07016.
   PubMedGoogle Scholar
• Saito Y, Uchida N, Tanaka S, Suzuki N, Tomizawa-Murasawa M, Sone A, Najima Y, Takagi S, Aoki Y, Wake A, Taniguchi S, Shultz LD, Ishikawa F. 2010. Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML. Nat. Biotechnol. 28:275–280. http://dx.doi.org/10.1038/nbt.1607.
   PubMed Web of Science ®Google Scholar
• de The H, Chen Z. 2010. Acute promyelocytic leukaemia: novel insights into the mechanisms of cure. Nat. Rev. Cancer 10:775–783. http://dx.doi.org/10.1038/nrc2943.
   PubMed Web of Science ®Google Scholar
• Masetti R, Biagi C, Zama D, Vendemini F, Martoni A, Morello W, Gasperini P, Pession A. 2012. Retinoids in pediatric onco-hematology: the model of acute promyelocytic leukemia and neuroblastoma. Adv. Ther. 29:747–762. http://dx.doi.org/10.1007/s12325-012-0047-3.
   PubMed Web of Science ®Google Scholar
• Beenken A, Mohammadi M. 2009. The FGF family: biology, pathophysiology and therapy. Nat. Rev. Drug Discov. 8:235–253. http://dx.doi.org/10.1038/nrd2792.
   PubMed Web of Science ®Google Scholar
• Goetz R, Mohammadi M. 2013. Exploring mechanisms of FGF signalling through the lens of structural biology. Nat. Rev. Mol. Cell Biol. 14:166–180. http://dx.doi.org/10.1038/nrm3528.
   PubMed Web of Science ®Google Scholar
• Miraoui H, Marie PJ. 2010. Fibroblast growth factor receptor signaling crosstalk in skeletogenesis. Sci. Signal. 3:re9. http://dx.doi.org/10.1126/scisignal.3146re9.
   PubMed Web of Science ®Google Scholar
• Acevedo VD, Ittmann M, Spencer DM. 2009. Paths of FGFR-driven tumorigenesis. Cell Cycle 8:580–588. http://dx.doi.org/10.4161/cc.8.4.7657.
   PubMed Web of Science ®Google Scholar
• Fillmore CM, Gupta PB, Rudnick JA, Caballero S, Keller PJ, Lander ES, Kuperwasser C. 2010. Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling. Proc. Natl. Acad. Sci. U. S. A. 107:21737–21742. http://dx.doi.org/10.1073/pnas.1007863107.
   PubMed Web of Science ®Google Scholar
• Ishiwata T, Matsuda Y, Yamamoto T, Uchida E, Korc M, Naito Z. 2012. Enhanced expression of fibroblast growth factor receptor 2 IIIc promotes human pancreatic cancer cell proliferation. Am. J. Pathol. 180:1928–1941. http://dx.doi.org/10.1016/j.ajpath.2012.01.020.
   PubMedGoogle Scholar
• Min H, Danilenko DM, Scully SA, Bolon B, Ring BD, Tarpley JE, DeRose M, Simonet WS. 1998. Fgf-10 is required for both limb and lung development and exhibits striking functional similarity to Drosophila branchless. Genes Dev. 12:3156–3161. http://dx.doi.org/10.1101/gad.12.20.3156.
   PubMed Web of Science ®Google Scholar
• Sekine K, Ohuchi H, Fujiwara M, Yamasaki M, Yoshizawa T, Sato T, Yagishita N, Matsui D, Koga Y, Itoh N, Kato S. 1999. Fgf10 is essential for limb and lung formation. Nat. Genet. 21:138–141. http://dx.doi.org/10.1038/5096.
   PubMed Web of Science ®Google Scholar
• Alderson R, Gohari-Fritsch S, Olsen H, Roschke V, Vance C, Connolly K. 2002. In vitro and in vivo effects of repifermin (keratinocyte growth factor-2, KGF-2) on human carcinoma cells. Cancer Chemother. Pharmacol. 50:202–212. http://dx.doi.org/10.1007/s00280-002-0493-8.
   PubMedGoogle Scholar
• Clark JC, Tichelaar JW, Wert SE, Itoh N, Perl AK, Stahlman MT, Whitsett JA. 2001. FGF-10 disrupts lung morphogenesis and causes pulmonary adenomas in vivo. Am. J. Physiol. Lung Cell. Mol. Physiol. 280:L705–L715. http://ajplung.physiology.org/content/280/4/L705.
   PubMed Web of Science ®Google Scholar
• El Agha E, Herold S, Al Alam D, Quantius J, MacKenzie B, Carraro G, Moiseenko A, Chao CM, Minoo P, Seeger W, Bellusci S. 2014. Fgf10-positive cells represent a progenitor cell population during lung development and postnatally. Development 141:296–306. http://dx.doi.org/10.1242/dev.099747.
   PubMedGoogle Scholar